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SUSCEPTIBILIDAD GENÉTICA DE OBESIDAD 
Y SÍNDROME METABÓLICO EN LA INFANCIA
Resumen
La obesidad es uno de los principales problemas de
salud pública a nivel mundial. Es una enfermedad cró-
nica, compleja y de origen multifactorial que se caracte-
riza por el exceso de grasa corporal y se desarrolla, funda-
mentalmente, debido a un desequilibrio entre la ingesta
dietética y el gasto energético. Una de las principales com-
plicaciones de la obesidad es el síndrome metabólico, el
cual comprende alteraciones antropométricas, clínicas y
metabólicas que predisponen el desarrollo de diabetes
mellitus tipo 2 y enfermedades cardiovasculares.Existe la
hipótesis de que tanto factores ambientales como genéti-
cos participan en la variabilidad a la susceptibilidad de
las complicaciones metabólicas mediadas por la obesidad.
Mientras que los avances en el conocimiento de las varia-
ciones en el genoma humano, han llevado a la identifica-
ción de genes que contribuyen a la susceptibilidad de la
obesidad y las enfermedades asociadas, son relativamente
pocos los estudios que se han centrado específicamente en
la interacción entre la obesidad y polimorfismos genéticos
relacionados con el desarrollo de complicaciones metabó-
licas o directamente con el síndrome metabólico. Además,
algunos de estos loci pueden tener mayor efecto en los
fenotipos metabólicos cuando está modificado por la
dieta u otrosfactores ambientales. En este manuscrito se
revisan los genes ylas variantes con mayor evidencia de
asociación con las complicaciones metabólicasrelaciona-
das con la obesidad descritas en estudios de asociación
genética, incluyendo estudios de genes candidatos y estu-
dios amplios del genoma humano en adultos y niños.
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Abstract
Obesity is one of the major public health problems
worldwide. It is a chronic, complex, and multifactorial-
origin disease characterised by body fat excess mainly
due to an imbalance between dietary intake and energy
expenditure. One of the major complications of obesity is
metabolic syndrome, which comprises anthropometrical,
clinical, and metabolic dysfunctions that predispose the
affected individual to the development of type 2 diabetes
mellitus and cardiovascular diseases. It is hypothesised
that the variability in the susceptibility to obesity-medi-
ated metabolic complications involves both environ-
mental and genetic factors. Whereas advances in the
knowledge of the variations in the human genome have
led to the identification of susceptibility genes that con -
tribute to obesity and related disorders, relatively few
studies have specifically focused on the interactions bet -
ween obesity and genetic polymorphisms and the devel-
opment of metabolic complications. Despite these limited
efforts, an increasing amount of evidence suggests that
the effects of some gene variants on metabolic traits are
modified by or present only in the setting of obesity. Fur -
thermore, some of these loci may have larger effects on
metabolic phenotypes in the presence of certain dietary
or lifestyle factors. In the present manuscript, we revie -
wed the genes and their variants that have been evidenced
to play a role in obesity-associated metabolic complica-
tions through genetic association studies, including candi-
date gene and genome-wide association approaches in
adults and children.
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Abbreviations
BMI: body mass index.
CVD: cardiovascular disease.






GWAS: genome-wide association studies.
BP: blood pressure.
OR: odds ratio.
SNP: single nucleotide polymorphisms.
PPARG: peroxisome proliferator-activated receptor
gamma.
TNF-a: tumour necrosis factor alpha.1
Introduction
Obesity, in addition to overweight, is the sixth major
cause of disease risk worldwide. It has been estimated
that 1 billion adults are currently overweight, and an
additional 475 million adults are obese. It has also been
estimated that 200 million school-aged children are
either overweight or obese worldwide and that 40-50
million of these children are classified as obese.1 The
obesity epidemic, which mainly affected developed
countries at the beginning, has extended to developing
countries, particularly their urban areas. Childhood
obesity has lead to an increase in morbidity and morta -
lity, which in turn result in high financial burdens for
health systems.
Childhood obesity is a condition in which excess
body fat negatively affects the child’s health and/or
wellbeing. This disease has been associated with seve -
ral comorbidities, such as cardiovascular events, hyper -
ten sion, insulin resistance (IR), dyslipidaemia, metabolic
syndrome (MetS), liver steatosis, orthopaedic pro blems,
and sleep apnoea, which can occur in either the short or
long term. Different studies have shown an association
between childhood obesity and the risk of cardiovascular
diseases (CVD) in adulthood,2 the early development of
atherosclerosis, changes in the BMI over time, and the
prediction of lipid and lipoprotein concentrations.3
Of all of the complications of obesity, a cluster of an -
thropometric, clinical, and metabolic alterations (low
levels of high-density lipoprotein-cholesterol (HDL-c),
high triacylglycerols (TAG), high blood pressure (BP),
and impaired glucose metabolism) form part of MetS,
which predisposes the affected individuals to the deve -
lopment of type 2 diabetes mellitus (T2DM) and CVD.4
The mechanisms linking obesity to its metabolic
com plications are extremely complex and remain hotly
debated. It is hypothesised that the variability in the
sus ceptibility to obesity-mediated metabolic complica-
tions involves both environmental and genetic factors.
Whereas advances in knowledge of the variations in the
human genome have led to the identification of suscepti-
bility genes that contribute to obesity and related disor-
ders, relatively few studies have specifically focused on
the interactions between obesity and genetic polymor-
phisms in the development of metabolic complications.
Despite these limited efforts, an increasing amount of
evidence, particularly related to adipokines and adipose
tissue, suggests that the effects of some gene variants on
metabolic traits are modified by or present only in the
setting of obesity. Furthermore, some of these loci may
have larger effects on metabolic phenotypes in the pre -
sence of certain dietary or lifestyle factors. In this chapter,
we review the small number of genes and their variants
that have been evidenced to have a role in obesity-associa -
ted metabolic complications.
Definition and prevalence of metabolic syndrome
The MetS diagnosis criteria are very well defined in
the adult population (table I).5 However, despite many
attempts, no consensus has yet been reached for the
diagnosis of MetS in children and adolescents.6,7 Many
authors, such as those cited in the study by Olza et al6,
have proposed different classifications, but methodolo -
gical and physiological limitations have complicated the
establishment of a definitive definition.7 The main diffi-
culties in the definition of the criteria are the following:
1. The measure of the adiposity excess with diffe -




The International Diabetes Federation metabolic
syndrome definition for adults
For a person to be defined as having metabolic syndrome, they must have
central obesity (defined through the waist circumference* with ethnicity spe-
cific values) plus any two of the following four factors:
Increased triglycerides ≥ 150 mg/dL (1.7 mmol/L) 
or specific treatment for this lipid abnormality
Reduced HDL-c < 40 mg/dL (1.03 mmol/L) in males
< 50 mg/dL (1.29 mmol/L) in females
or specific treatment for this lipid abnormality
Increased blood pressure systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg
or treatment of previously diagnosed 
hypertension
Increased fasting FPG ≥ 100 mg/dL (5.6 mmol/L),
plasma glucose or previously diagnosed type 2 diabetes
If above 5.6 mmol/L or 100 mg/dL, OGTT is
strongly recommended but is not necessary to
define the presence of the syndrome.
*If the BMI is greater than 30 kg/m², central obesity can be assumed and the waist cir-
cumference does not need to be measured. HDL-c, high-density lipoprotein-choleste-
rol; BP, blood pressure; FPG, fasting plasma glucose; OGTT, oral glucose tolerance
test; BMI, body mass index. Adapted from ref. 5. For ethnicity-specific waist circum-
ference values, see this reference.
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2. The extrapolation of the cut-off values from the
adult population.
3. The lack of ethnicity- and sex-specific charts
with separate cut-off values for the prepubertal
and the pubertal populations. 
4. The physiological pubertal changes that tempora -
rily modify the plasma hormones levels have not
been taken into account.
5. The measurement of the glucose metabolism dys -
function with a fasting plasma glucose test or an oral
glucose tolerance test instead of IR, e.g., homeo-
static model of insulin resistance (HOMA-IR).
6. Factors such as physical activity or environ-
mental conditions that have not been taken into
account.
7. The lack of inclusion of other biomarkers (e.g.,
proinflammatory and/or prothrombotic factors)
that might contribute to the identification of the
syndrome, particularly at the early onset.
Due to the abovementioned problems, it is very di ffi -
cult to epidemiologically monitor MetS. The preva-
lence rates depend on the definition used for its classifi-
cation, but, given that MetS is driven by obesity, the
pre valence of the latter will strongly influence the pre -
valence of MetS8. Recently, our group showed that the
percentage of MetS in Spanish prepubertal obese chil-
dren varies from 7.6% to 30.8% in the same population
depending on the definition used.7 In a recent system-
atic review conducted by Friend et al9, the prevalence
of MetS in a paediatric population was studied (inclu -
ding 85 studies) using the three most used definitions
(International Diabetes Federation, National Choles-
terol Education Program’s Adult Treatment Panel III
and World Health Organisation). The results of the
review showed that the median prevalence of MetS
was 3.3% (range of 0% to 19.2%) in the whole popula-
tion, 11.9% (range of 2.8% to 29.3%) in the overweight
population, and 29.2% (range of 10.0% to 66.0%) in
the obese population. These data reinforce the neces-
sity of unifying criteria and establishing a unique defi -
nition that encompasses all of the variables involved in
the development of the syndrome. In the search of a
methodology to overcome this barrier, one promising
approach has been the use of the measurements of the
MetS components as continuous variables to obtain a
sum of the z-scores of each component that can be used
to quantify the risk7. It has been shown that the use of
this cluster would better identify the at-risk paediatric
population compared with the use of the most common
five components in the definition of this syndrome.
Origin of metabolic syndrome
The aetiology of MetS is not completely clear; ho -
we ver, the evidence indicates that IR, inflammation,
and obesity are the three factors that converge to cause
all of the metabolic changes that intervene in the deve -
lopment of MetS (fig. 1). Nevertheless, other factors,
such as the environment, diet, physical inactivity, ge ne -
 tic predisposition, age, ethnicity, and some drugs, are
involved in the development of the syndrome.
Individuals with IR increase their insulin production
to force glucose into the peripheral tissues. In fact, each
tissue exhibits differential insulin sensitivity, but the
liver appears to be where the disorder starts. The increa -
se in the free fatty acid (FFA) flux within the liver,
either by de novo lipogenesis or by FFA delivery via the
portal vein, impairs the hepatic insulin action, which
leads to an increase in the hepatic glucose output, the
synthesis of proinflammatory cytokines, the TAG syn -
Fig. 1.—Metabolic disorders
and inflammation in the me-
tabolic syndrome.
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the sis, the intrahepatic lipid deposition, and the ectopic
lipid accumulation.4 The excess TAG is released with
apolipoprotein B as VLDL, the HDL-c secretion dimi ni -
shes, and the number of relatively cholesterol-de pleted
small dense low-density lipoprotein particles increase.
These changes in the lipoprotein metabolism are consi -
dered the primary cause for MetS dyslipidemia.10
IR in the adipose tissue is also important in the deve -
lopment of MS. The expanded adipose tissue increases
lipolysis and releases FFA due to a reduced antilipoly -
tic effect and the loss of inhibition of the hormone-
sensitive lipase. The FFAs drain to the liver via the por -
tal vein and increase the hepatic FFA accumulation to
create a vicious circle between the liver and the adipose
tissue. The changes in the expanding adipose tissue pro -
mo te the transition to a metabolically dysfunctional
phe notype. Whereas the macrophages in lean adipose
tissue express markers of M2, the macrophages in obe -
se tissue lead to the recruitment and accumulation of
M1 and T cells, which indicates the infiltration of the
tissue and the formation of crown-like structures and
results in the accumulation of macrophages around
dead adipocytes in inflamed adipose tissue.11 The meta-
bolic dysfunction also stimulates the production of
large amounts of pro-inflammatory factors and cytoki -
nes as interleukins, leptin, tumour necrosis factor alpha
(TNF-a), resistin and plasminogen activator inhibitor-1,
that have effects in other tissues such as liver or skele tal
muscle but also acts in a paracrine way.7,11
The skeletal muscle is an important contributor to
the glucose homeostasis, and the liver IR contributes to the
disruption of the glucose-fatty acid cycle and the insu -
lin-mediated glucose uptake by skeletal muscle, which
facilitates the development of hyperglycaemia. The
accumulation of FFAs in the muscle worsens the IR to
induce the impairment of insulin signalling.12
Evidence for a genetic component 
Obesity is a complex trait that stems from a compli-
cated network of contributory components, including
genomic and environmental factors, the aggregations
of which increase the probability of disease. Sedentary
behaviours and high-calorie diets are the major envi-
ronmental factors that drive the epidemic of obesity.
Studies in twins, no twin siblings, and adoptees have
shown that genetic components contribute from 40% to
70% to the interindividual variation in common obesi -
ty.13 The influence of both family history and childhood
obesity on the obesity risk in young adulthood was
assessed by Whitaker et al,14 who showed that the influ-
ence of having one obese parent throughout childhood
and adolescence increases an individual’s risk of adult
obesity by 2.2- to 3.2-fold compared with someone
whose parents were not obese. Having two obese pa -
rents during childhood and adolescence substantially
increases the risk of being an obese adult, with ORs
(odds ratios) ranging from 5 to 15.30, compared with
someone who had no obese parents, with the exception
of parental obesity at the age of 10 to 14 yrs. The influ-
ence of obesity during childhood and adolescence on
the risk of adult obesity increases steadily with age.
Whe reas obesity during infancy (1-2 yrs) does not
increase one’s risk of being an obese adult, an obese
child at the age of 10 to 14 yrs has a 22.30-fold increa -
sed risk of being an obese adult compared to someone
who was not obese as a child. Therefore, without a
doubt, the obese phenotype runs prevalently in families,
but most of the causative genes are still undisco vered. 
Furthermore, the high clustering of components in
family and twin studies has implied the importance of a
genetic contribution to MetS. In a seminal study of
2,508 male twin pairs, concordance for the clustering
of three MetS components (hypertension, diabetes, and
obesity) was found in 31.6% of the monozygotic pairs
compared with 6.3% of the dizygotic pairs.15 Similarly,
among 236 female twin pairs, the heritability estimates
for obesity, insulin/glucose, and dyslipidaemia were
found to be 61%, 87%, and 25%, respectively, using a
classical non-molecular approach. This finding indi-
cates an important genetic contribution for each of
these components.16 Among 803 individuals from 89
Caribbean-Hispanic families in the Northern Manha -
ttan Family Study, the heritability of MetS itself was
found to be 24%, with significant heritability for the
lipid/glucose/obesity (44%) and hypertension (20%)
components.17 The marked variability in the heritability
between studies might be partly attributable to ethni -
city. Based on these demonstrations of heritability for
MetS and its components, several investigators have
directly examined the genetic determinants for MetS
using linkage or association studies. 
Genetics of obesity and metabolic syndrome
Hundreds of candidate genes for obesity suscepti-
bility have been identified through a variety of approa -
ches, as revised by Rankinen et al:18 animal studies,
Mendelian syndromes, linkage studies, genetic associa -
tion studies, and expression studies. Since the mid-
1990s, candidate gene studies have aimed to identify
obesity-susceptibility genes. Candidate gene studies are
hypothesis-driven, and hundreds of genes for which
there is some evidence that supports a role in the regu-
lation of the energy balance in animal models or in ex -
tre me/monogenic forms of obesity have been tested to
determine their association with obesity-related traits.18
However, consistent associations have been reported
for only a handful of these candidate genes. The main
reasons for the limited success of the candidate gene
approach include the small sample sizes used and thus
the low statistical power, the low number of genetic
variants tested per gene and thus the incomplete cove -
ra ge of the common variations, and the limited biolo -
gical insights that provide the basis for the gene candi-
dacy. The advent of genome-wide association studies
(GWAS) in 2005 changed the way and the speed through
47
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which genetic loci are discovered. The completion of
the Human Genome Project and the HapMap project, in
conjunction with the development of high-throughput
genotyping techniques and statistical and computa-
tional methods, have enabled large-scale GWAS, in
which a large number of genetic variants are tested for
association with the trait of interest. To adjust for the
vast number of tests performed in GWAS, procedures
such as multiple testing correction and replication in
independent samples are undertaken to minimise the
number of false discoveries. Among the strongest argu-
ments in favour of performing GWASs is the fact that
such studies are hypothesis-free, i.e., the whole
genome is screened for association to a complex disea -
se or trait without prior hypotheses about which genes
or regions are likely to be associated. The results of
numerous GWASs performed in recent years have
justified this approach because many previously unsus-
pected regions have been reproducibly associated with
numerous complex traits.
Nevertheless, interest remains in the analysis of
candidate genes. With GWAS data now available on
nu merous large cohorts, it has become possible to em -
bed candidate gene studies within GWAS to test the
association of a much larger number of candidate genes
than previously possible. Recent studies have exami -
ned whether those obesity candidate genes are enriched
for associations with BMI compared with non-candi-
date genes using data from a large-scale GWAS. The
authors concluded that the candidate genes are more
likely to be truly associated than the non-candidate
genes, at least in the obesity-susceptibility evidence
that supports the enrichment of the association of can -
didate genes, which suggests that the candidate gene
approach retains some value. However, the degree of
enrichment is small despite the extensive number of
candidate genes and the large sample size. Studies that
focus on candidate genes have only slightly increased
chances of detecting associations and are likely to miss
many true effects in non-candidate genes, at least for
obesity-related traits.19
Genome-wide association studies of obesity 
and metabolic syndrome
To date, GWASs have provided robust evidence for
a role of some variants, particularly the FTO, MC4R
and TMEM18 loci, in the development of obesity. The
vast majority of these studies have been performed in
white Europeans and in adults and have identified 32
loci that reached genome-wide significance. These stu -
dies were recently revised.19,20 Table II reports the genes
that have so far been found to be associated with obe -
sity (BMI). The search for genetic factors that specifi-
cally influence paediatric obesity-related outcomes has
primarily focused on replicated candidate genes in adult
studies. In a study performed by Willer et al,21 the ana -
lysis was conducted using a study sample from the Avon
Longitudinal Study of Parents and Children (ALSPAC;
N = 4,951 with BMI information at age 11) and confir -
med significant associations of variants in/near FTO,
MC4R, TMEM18, KCTD15, and GNPDA2 with the
BMI. Successively, the data were replicated in a cohort
of obese children (N = 1,038) from the United Kingdom
cohort of the Severe Childhood Onset Obesity Project,
and an increased risk of extreme childhood obesity was
revealed for the BMI-increasing alleles near TMEM18,
GNPDA2, and NEGR1.22 In the European Youth Heart
Study (1,252 children and 790 adolescents), the associ-
ations of 15 variants (NEGR1, SEC16B, LYPLAL1,
TMEM18, ETV5, GNPDA2, TFAP2B, MSRA, BDNF,
MTCH2, BCDIN3D, NRXN3, SH2B1, FTO, MC4R,
and KCTD15) with BMI were similar to those observed
in adults.23 In a meta-analysis data of 13,071 children
and adolescents, significant associations with BMI we -
re found for 9 of 13 variants, and a region near to the
TMEM18 variant had the strongest effect. The effect on
the BMI tended to be more pronounced for variants
in/near SEC16, TMEM18, and KCTD15 in children and
adolescents compared with adults.24
Several extensive and successful efforts have been
made to map variants associated with the components
of MetS. Studies using MetS as a binary trait and stu -
dies investigating the components using bivariate or
multivariate methods have been published in the last
few years. However, bivariate methods may be consi -
dered somewhat paradoxical because three or more
components are used to define the syndrome. More-
over, it should be noted that a number of investigators
within the scientific community do not agree that MetS
is an entity in itself, but a set of risk factors for cardio -
metabolic disease that are useful to the biological un -
der standing. Zabaneh and Balding25 conducted a two-
stage GWAS to identify common genetic variations
that alter the risk of MetS and related phenotypes in
Indian Asian men, who exhibit a high prevalence of
these conditions. In stage 1, approximately 317,000
SNPs were genotyped in 2,700 individuals, and 1,500
of these SNPs were selected to be genotyped in an addi-
tional 2,300 individuals. No evidence of a common
genetic basis for the MetS traits was found in this stu -
dy. Another approach was used in the study performed
by Kraja et al,26 which grouped seven country-studies
from the STAMPEED consortium, comprising 22,161
participants of European ancestry, who underwent
bivariate genome-wide association analyses of meta-
bolic traits. The phenotypes for MetS were combined
in all possible pairwise combinations, and those indi-
viduals who exceeded the thresholds for both traits of a
pair were considered affected. Twenty-eight SNPs
were associated with MetS or a pair of traits. These va -
riants were located in or near 15 genes that were associ-
ated with binary pairwise traits or with MetS per se at
the genome-wide significance level. All but two of the -
se bivariate associations included a lipid abnormality.
The authors suggested that these results show that the
genetic effects on lipid levels are more pronounced
48
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Table II
Genetic variants associated with obesity and metabolic syndrome through genome-wide association studies (GWAS)
Nearest gene Full gene name SNP Trait






MC4R Melanocortin 4 receptor rs571312 BMI*
rs12970134 BMI*
TMEM18 Transmembrane protein 18 rs2867125 BMI*
rs6548238 BMI*
rs7561317 BMI*
SEC16B SEC16 homolog B rs543874 BMI*
rs574367 BMI
rs516636 BMI*




GNPDA2 Glucosamine-6-phosphate deaminase 2 rs10938397 BMI*
SH2B1 SH2B adaptor protein 1 rs7359397 BMI*
rs7498665 BMI
ETV5 Ets variant 5 rs9816226 BMI*
rs7647305 BMI
NEGR1 Neuronal growth regulator 1 rs2815752 BMI*
rs2568958 BMI*
TFAP2B Transcription factor AP-2 beta (activating enhancer binding rs987237 BMI*
protein 2 beta)
NRXN3 Neurexin rs10150332 BMI*
FAIM2 Fas apoptotic inhibitory molecule 2 rs7138803 BMI
MTCH2 Mitochondrial carrier 2 rs3817334 BMI
rs10838738 BMI
KCTD15 Potassium channel tetramerisation domain containing 15 rs29941 BMI*
rs11084753 BMI
SLC39A8 Solute carrier family 39 (zinc transporter), member 8 rs13107325 BMI
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than for other traits. The most influential variants in the
correlation among traits were in or near LPL, CETP,
APOA5, ZNF259, BUD13, TRIB1, LOC100129500, and
LOC100128154. The genes with variants that in flue n -
ce MetS per se included LPL, CETP, and the APOA-
cluster (APOA5, ZNF259, and BUD13), which are known
to play an important role in lipid metabolism.26
Another approach that combined several compo-
nents of MetS in a GWAS was published by Avery et
al,27 who used data from 19,486 European Americans
and 6,287 African Americans. Six phenotype domains
(atherogenic dyslipidemia, vascular dysfunction, vas -
cu lar inflammation, pro-thrombotic state, central obe -
sity, and elevated plasma glucose), including 19 quan-
titative traits, were examined and analysed through a
principal component analysis. These researchers then
applied a multivariate approach that related eight prin-
cipal components from the six domains. In European
Table II (cont.)
Genetic variants associated with obesity and metabolic syndrome through genome-wide association studies (GWAS)
Nearest gene Full gene name SNP Trait
GPRC5B G protein-coupled receptor, family C, group 5, member B rs12444979 BMI
PRKD1 Protein kinase D1 rs11847697 BMI
QPCTL Glutaminyl-peptide cyclotransferase-like rs2287019 BMI
rs11671664 BMI
MAP2K5 Mitogen-activated protein kinase 5 rs2241423 BMI
rs4776970 BMI
LRRN6C Leucine rich repeat neuronal 6C rs10968576 BMI
FANCL Fanconi anaemia, complementation group L rs887912 BMI
CADM2 Cell adhesion molecule 2 rs13078807 BMI
TMEM160 Transmembrane protein 160 rs3810291 BMI
LRP1B Low-density lipoprotein receptor-related protein 1B rs2890652 BMI
MTIF3 Mitochondrial translational initiation factor 3 rs4771122 BMI
TNNI3K TNNI3-interacting kinase rs1514175 BMI
ZNF608 Zinc finger protein 608 rs4836133 BMI
PTBP2 Polypyrimidine tract-binding protein 2 rs1555543 BMI
RPL27A Ribosomal protein L27a rs4929949 BMI
NUDT3 Nudix (nucleoside diphosphate linked moiety X)-type motif 3 rs206936 BMI
LPL Lipoprotein lipase rs295 MetS
CETP Cholesteryl ester transfer protein, plasma rs173539 MetS
APOA5 Apolipoprotein A-V rs2266788 MetS
ZNF259 Zinc finger protein 259 rs2075290 MetS
BUD13 BUD13 homolog (S. Cerevisiae) rs10790162 MetS
APOC1 Apolipoprotein C-I rs4420638 MetS
BRAP BRCA1-associated protein rs11065987 MetS
PLCG1 Phospholipase C, gamma 1 rs753381 MetS
APOA1/C3/A4/A5 Gene cluster region (SNP rs964184) rs964184 MetS
* Association observed in children. BMI: body mass index. MetS: metabolic syndrome.
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Americans, these researchers identified genome-wide
significant SNPs representing 15 loci. Many of these
loci were associated with only one trait domain, and
five of these associations were consistent with the re -
sults obtained with the cohort of African Americans. In
addition, several of these associations were already
known, e.g., the association of central obesity with
FTO. However, the study identified three new loci in or
near APOC1, BRAP, and PLCG1, which were associ-
ated with multiple phenotype domains. The strongest
new pleiotropic signal in European Americans was
observed for rs4420638, which is located near APOC1
and was associated with elevated plasma, atherogenic
dyslipidemia, vascular inflammation, and central obe -
sity. A recent GWAS on MetS and its component traits
in four Finnish cohorts consisting of 2,637 MetS cases
and 7,927 controls (all of the individuals in both cohorts
were free of diabetes) suggested that genes from the
lipid metabolism pathways have a key role in the ge -
netic background of MetS. The lipid locus at the APOA1/
C3/A4/A5 gene cluster region (SNP rs964184) was
associated with MetS in all four study samples. Interes -
tingly, the association was further supported by the re sults
from a serum metabolite analysis, in which rs964184 was
associated with various VLDL, TAG, and HDL-c me -
tabolites. Most of these metabolites were associated
with lipid phenotypes, and none of them were associa -
ted with two or more uncorrelated MetS components.
A genetic risk score, which was calculated as the num -
ber of alleles in a loci associated with individual MetS
traits, was strongly associated with the MetS status.28
Nevertheless, further replication is needed, and, if the -
se pleiotropic loci hold true, these loci may help cha -
racterise metabolic deregulation and identify targets
for intervention. In addition, to the best of our know -
ledge, no GWAS has been performed in children; thus,
this is mandatory.
Candidate gene association studies
of metabolic syndrome
Because glucose metabolism, insulin signalling, adi -
po kines, and inflammation are thought to play crucial
roles in MetS pathogenesis, it may be fruitful to exami -
ne candidate genes from these areas for MetS. Table III
lists the reported candidate genes associated with an
increased or decreased risk for MetS. The main find-
ings reported by candidate gene associations studies of
the main metabolic pathways involved in MetS are
reviewed below.
Glucose metabolism and insulin signalling
The genetic basis of T2DM, glucose homeostasis
(fasting plasma glucose and insulin), and indirect mea -
sures of IR (HOMA-IR) have been demonstrated by
GWAS and meta-analyses of individual case-control
studies. More than 50 loci have been found to be asso-
ciated with the risk of T2DM, and the strongest effect
was observed with the rs7903146 in the TCF7 L2 gene.
In a meta-analysis of 21 GWAS cohorts (Meta-Analyses
of Glucose and Insulin-related traits Consortium [MA -
GIC]),29 robust statistical evidence for the genome-
wide association with fasting glucose was observed for
SNPs in eight loci (including the candidate genes ADCY5,
FADS1, and GLIS3) and SNPs in one locus (with the
candidate gene IGF1). Expanding upon MAGIC, a joint
meta-analysis was conducted to determine whether
genes involved in the IR pathways (HOMA-IR) could
be discovered by accounting for differences in obesity
(BMI) and interactions between the BMI and genetic
variants.30 The discovery of SNPs in six loci (including
the candidate genes COBLL1/GRB14, IRS1, PPP1R3B,
PDGFC, UHRF1BP1, and LYPLAL1) that were asso-
ciated with fasting insulin, high TAG levels, and low
HDL-c levels suggested a new series of pathways that
can be studied to identify genes with contributions to
multiple phenotypes. 
The associations of genetic variants in insulin signa -
lling have been reported to be associated with MetS. In
a recent association study with 1,886 participants from
the EPIC-NL cohort, a group of five SNPs were found to
be related with IR (IRS1 rs2943634, PPARG rs1801282,
GCKR rs780094, GCK rs1799884, and IGF1 rs35767),
and the IRS1 SNP was the only one that was significantly
associated with MetS and the MetS score. This SNP was
also associated with HbA1C, TAG, and HDL-c.31 Seve -
ral studies have indicated that INPPL1 gene polymor-
phisms may be associated with the MetS and/or T2DM.
In a British cohort, three SNPs in the INPPL1 gene were
significantly associated with components of MetS, such
as hypertension, obesity, and T2DM, although the
findings could not be replicated in French subjects.32 In
a recent cross-sectional study with 1,328 participants
with MetS and 1,074 controls without MetS, two SNPs
of INPPL1, rs2276048 (silent mutation) and rs2276047
(intronic) were found to be associated with MetS in
men.33
Lipid metabolism
Genes related to lipid metabolism have been descri -
bed to be strongly associated with MetS. The determi-
nants of the plasma TAG metabolism might be determi-
nants of MetS, and genetic variants have been re vi sed
by Joy et al.34 Apolipoprotein C-III is present in TAG-
rich lipoproteins and inhibits lipoprotein lipase, there -
by delaying the catabolism of TAG. A case-control
study consisting of whites, South Asians, and blacks
demonstrated that the APOC3 promoter polymor-
phisms –482C > T and –455 T> C were associated with
MetS. Among 1,788 Japanese individuals, of whom
1,017 had MetS and 771 were controls, the APOA5 
–1131T > C polymorphism was strongly associated
with MetS prevalence, and the C allele was signifi-
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cantly related to increased TAG and decreased HDL-c
levels. In contrast, a study of 3,124 white individuals
from Germany and Austria did not find an association
between the APOA5 –1131T > C polymorphism and
MetS, but did discover that the APOA556C > G variant
conferred an increased risk of MetS. These varied
results in genetic associations are likely due to ethnic
differences. In addition, the lipoprotein lipase S447X
variant has been associated with MetS in Turkish wo -
men. In particular, this study showed that females with
the more common SS genotype had a significantly
increased likelihood for MetS and low HDL-c levels.
Table III
Genetic variants associated with obesity and metabolic syndrome through genome-wide association studies (GWAS)
Nearest gene Full gene name Trait
ADCY5 Adenylate cyclase 5 Increased fasting glucose
ADIPOQ Adiponectin Decreased risk of obesity, MetS, and T2DM and high adiponectin
APOA5 Apolipoprotein A-V Increased TAG and decreased HDL-c
APOC3 Apolipoprotein C-III Increased TAG and decreased HDL-c
COBLL1/GRB14 Cordon-bleu WH2 repeat protein-like 1 growth Increased fasting insulin and TAG and decreased HDL-c 
factor receptor-bound protein 14
FABP4 Fatty acid binding protein 4 Increased HOMA-IR and FABP4 levels in children
FADS1 Fatty acid desaturase 1 Increased fasting glucose
ENPP1 Nucleotide pyrophosphatase/phosphodiesterase-1 Increased fasting insulin and risk of MetS in children
GLIS3 GLIS family zinc finger 3 Increased fasting glucose
IGF1 Insulin-like growth factor 1 (somatomedin C) Increased fasting glucose
IL6 Interleukin 6 Increased risk of MetS
INPPL1 Inositol polyphosphate phosphatase-like 1 Increased systolic and diastolic blood pressure, obesity, and T2DM
IRS1 Insulin receptor substrate 1 Increased fasting insulin and TAG and decreased HDL-c
INS VNTR Insulin variable number of tandem repeats Increased fasting insulin and risk of MetS in children
LPL Lipoprotein lipase Decreased fasting HDL-c
LYPLAL1 Lysophospholipase-like 1 Increased fasting insulin and TAG and decreased HDL-c
MCP1 Monocyte chemoattractant protein 1 Increased risk of MetS
PDGFC Platelet derived growth factor C Increased fasting insulin and TAG and decreased HDL-c
PLIN4 Perilipin 4 Increased risk of MetS in children and adolescents
PPARG Peroxisome proliferator-activated receptor gamma Increased abdominal circumference and TAG and decreased HDL-c
PPP1R3B Protein phosphatase 1, regulatory subunit 3B Increased fasting insulin and TAG and decreased HDL-c
RSTN Resistin Increased TAG, BMI, and systolic and diastolic blood pressure
SR-BI Scavenger receptor class B type I Decreased fasting HDL-c and increased risk of MetS in children
TCF7 L2 Transcription factor 7-like 2 Increased fasting glucose
TNFA Tumour necrosis factor a Increased systolic blood pressure and obesity in adults and children
UHRF1BP1 UHRF1-binding protein 1 Increased fasting insulin and TAG and decreased HDL-c
ZFP36 ZFP36 ring finger protein Increased fasting glucose and LDL-c
TAG: triacylglycerides. HDL-c: high-density lipoprotein-cholesterol. LDL-c: low-density lipoprotein-cholesterol. MetS: metabolic syndrome. T2DM:
type 2 diabetes mellitus.
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Interestingly, in a recent systematic review, the 56C > G
(APOA5), –1131T > C (APOA5), –482C > T (APOC3),
and –455T > C (APOC3) polymorphisms were more
prevalent in subjects with MetS.31 Thus, genetic varia-
tions affecting TAG metabolism might be associated
with the composite MetS phenotype.
In addition to genes involved in the TAG metabo-
lism, peroxisome proliferator-activated receptor gam -
ma (PPARG), which is a nuclear receptor involved in
glucose and fatty acid metabolism, has been associa ted
with obesity and MetS. The Pro12Ala (rs1801282)
polymorphism of the PPARG gene has been consis-
tently associated with T2DM. However, although 16
studies have investigated the association between
Pro12Ala (rs1801282) and MetS, as discussed in a
systematic review,35 most of these showed no effect.
Interestingly, although the 12Pro allele is associated
with an increased risk of T2DM and IR independent of
BMI, the meta-analysis demonstrates that 12Ala is the
risk allele if any effect on MetS exists. The association
between C1431T (rs3856806), which is another well-
known PPARG polymorphism, and MetS has been
investigated in six cross-sectional studies, which are
included in the same meta-analysis, and no association
was found between this SNP and MetS. Although both
the 12Ala and the C1431T alleles do not appear to
significantly increase the MetS risk, a haplotype con -
taining the same alleles was associated with an increa -
sed prevalence of MetS in a cross-sectional study of
1,115 French subjects.36 Other SNPs in the PPAR
family of genes have been studied. A study of French-
Canadian men revealed no association between the
PPARA L162 V polymorphism and MetS despite the
higher frequency of this polymorphism in men exhibi -
ting increased abdominal circumference, high TAG
levels, and low HDL-c levels. The PPARD –87T>C
polymorphism in French-Canadian men and women
conferred protection from the MetS phenotype, and
this protection was further enhanced if the carriers
consumed less than 34.4% calories from fat, which
suggests a gene-environment interaction.37
Adipokines
In humans, several polymorphisms in leptin (LEP),
leptin receptor (LEPR), resistin (RETN), adiponectin
(ADIPOQ), adiponectin receptor 1 (ADIPOR1), and
adiponectin receptor 2 (ADIPOR2) have been found to
be associated with obesity and MetS phenotypes. A
recent metanalysis that included 21 polymorphisms in
seven genes that were significantly associated with
obesity suggested that only polymorphisms in ADIPOQ
decreased the risk of obesity, whereas polymorphisms
in the LEP, LEPR, and RETN genes were not related to
the development of obesity.38 Interestingly, some of
these genetic variants have been associated with MetS.
Among 1,438 Taiwanese individuals, the G allele of
the ADIPOQ SNPrs1501299 in intron 2 was associated
with decreased risk of obesity, MetS, and T2DM.39 The
examination of the –420C>G SNP in the RSTN gene
revealed that G/G homozygotes had an increased pre -
va len ce of MetS and elevated TAG, BMI, and systolic
and diastolic BP values compared with the other geno-
types. In a follow-up case control study, the RSTN
–420C > G SNP was associated with an increased MetS
prevalence but did not influence the MetS prevalence
among individuals at high cardiovascular risk.40 Recen tly,
64 tagging SNPs in ADIPOQ, ADIPOR1, and ADIPOR2
were genotyped in two general population cohorts
consisting of 2,355 subjects and one cohort of 967 sub -
jects with T2DM. A genetic variation in ADIPOQ, but
not in its receptors, was associated with altered serum
adiponectin. However, genetic variations in ADIPOQ
and its receptors do not appear to contribute to the risk
of IR or MetS.41
Inflammation
Proinflammatory cytokines, such as interleukin-6,
TNF-a, and monocyte chemoattractant protein-1
(MCP1), are postulated to have a role in the MetS pa tho -
genesis and represent candidate genes. The main finding
in adults was revised by Joy et al.34 Among 6,916 Danes,
the AGC/GGG haplotype of three common IL6 promo -
ter polymorphisms were more common among the
adults with MetS compared with the controls without
MetS. The examination of the IL6 –174G > C promoter
polymorphism in 571 whites revealed a higher MetS
prevalence among those individuals with the CC geno-
type. Conversely, a population-based sample of 1,630
Germans revealed that none of the seven SNPs of the
proinflammatory cytokine MCP1 gene were associated
with MetS. In addition, although a meta-analysis of 31
studies revealed that the TNFA –308G>A polymorphism
conferred a risk of 1.23 for obesity and an increase in
the systolic BP of 3.5 mm Hg, the relationship of this
polymorphism with MetS was not examined. Zinc fin -
ger protein 36 (ZFP36), which is involved in TNF-a
regulation, has been proposed as a candidate gene for
MetS based on its position on the long arm of chromo-
some 19, which is a region linked with MetS that exhibits
significant differential expression (4.6-fold higher)
among obese individuals without MetS compared with
those with MetS. In the same study, the ZFP36 rs251864
polymorphism was associated with a lower body weight
among women and the T allele was associated with
glucose levels in men. Furthermore, the ZFP36 haplo-
type was associated with plasma low-density lipoprotein
in men and women. Thus, future studies might replicate
the ZFP36 association with MetS.
Association studies of metabolic syndrome in children
Candidate gene association studies that search for
factors that specifically influence paediatric obesity
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and metabolic-related outcomes are limited and scarce
in the scientific literature. The main limit is the sample
size, most likely due to the abovementioned difficulty
associated with the epidemiological monitoring of
MetS depending on the definition used for its classifi-
cation. Those studies that investigated genes involved
in glucose metabolism, insulin signalling, adipokines,
and inflammation in at least 100 obese children are
briefly summarised below. 
The T allele of the rs997509ENPP1 (nucleotide py -
ro phosphatase/phosphodiesterase-1) gene has been
found to predispose obese children to MetS and IR in
409 obese children compared with 400 lean controls.42
The insulin variable number of tandem repeats (VNTR)
polymorphism located in the insulin gene promoter
(INS VNTR) has been associated with the insulin levels
in obese children and was found predispose 320 obese
children to develop the MetS43 Several genes involved
in lipid metabolism have been associated with child-
hood MetS risk. The rs5888 in the scavenger receptor
class B type I (SR-BI) gene, which plays a role in cho -
les teryl esters-HDL metabolism, was associated with
MetS in 39 children diagnosed with the syndrome com -
pared with 124 children with simple obesity.44 The pre -
sen ce of selective SNPs in the FABP4 gene increased
HOMA-IR and FABP4 levels in 309 children aged 5-7
years, although the MetS classification was not consi -
dered in this study.45 The minor A allele in PLIN4 was
associated with a higher risk of MetS in 234 obese chil-
dren and adolescents.46 In addition, two inflammation
genes associated with MetS in adults have also been
studied in children. The TNFA –308G > A polymor-
phism was more common in 124 children with simple
obesity; however, it did not appear to be associated with
the degree of obesity, insulin resistance, lipid profile,
leptin levels, or the incidence of MetS in obese chil-
dren.47 The IL6 –174G > C promoter polymorphism did
not appear to be associated with obesity or with the
incidence of MetS in 124 obese children.48
Conclusion
MetS represents a complex phenotypic trait consis -
ting of several clinical factors associated with an in -
crea sed risk of T2DM and CVD. Genetic studies in adults
and children have provided conflicting associations of
genes and gene variants rather than consistently repro-
ducible associations and linkages. Nonetheless, the ho -
pe remains that understanding the genetic determinants
of MetS will lead to early detection of new cases and
possible preventive strategies based on the important
caveats for genetic studies of complex traits. Thus,
although genetics likely plays a crucial role in MetS
development, the elucidation of the exact genes invol -
ved has been hindered by the lack of a consistent MetS
definition, the varying combination of phenotypes
even within a single definition, ethnic disparities, and
gender influences. Furthermore, the lifestyle determi-
nants for MetS development should not be ignored, and
these determinants are also likely under genetic con -
trol. In short, MetS development represents an intricate
interaction between genetic susceptibilities and envi-
ronmental influences, and genetic studies increase our
appreciation of this complexity.
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